Oramed Pharmaceuticals Inc. — Major Shareholding Notification 2019

Jul 21, 2019

FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB Number: 3235-0104 Estimated average burden

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

* 1. Name and Address of Reporting Person Xiaoming Gao			2. Date of Event Requiring Statement (Month/Day/Year) 07/01/2019		3. Issuer Name and Ticker or Trading Symbol ORAMED PHARMACEUTICALS INC. [ ORMP ]
(Last) (First) (Middle)					4. Relationship of Reporting Person(s) to Issuer (Check all applicable)			5. If Amendment, Date of Original Filed (Month/Day/Year)
11F. NO. 266 HANKOU ROAD HUANGPU DISTRICT (Street) SHANGHAI F4 2000001					X Director Officer (give title below)	10% Owner Other (specify below)		6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting X Person Form filed by More than One Reporting Person
(City)	(State)	(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)					2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)		4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock					1,155,367	I (1)		By Hefei Tianhui Incubator of Technologies Co., Ltd.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) Date Exercisable				3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or	5. Ownership Form:	6. Nature of Indirect Beneficial Ownership (Instr. 5)
				Expiration Date	Title	Amount or Number of Shares	Exercise Price of Derivative Security	Direct (D) or Indirect (I) (Instr. 5)

Explanation of Responses:

1. Mr. Gao is an indirect beneficial owner and chairman of Hefei Tianhui Incubator of Technologies Co., Ltd. ("HTIT"). HTIT holds 1,155,367 shares of common stock of the issuer. Mr. Gao disclaims beneficial ownership in the securities owned by HTIT except to the extent, if any, of his pecuniary interest therein.

** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

SEC Form 3

OMB APPROVAL

hours per response: 0.5